A study to test how well different doses of BI 3804379 are tolerated by healthy people and patients with MASH
1524-0001
Phase 1 other active
Quick answer
A study to test how well different doses of BI 3804379 are tolerated by healthy people and patients with MASH for Metabolic Dysfunction-associated Steatohepatitis is a Phase 1 program (other) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Metabolic Dysfunction-associated Steatohepatitis
- Phase
- Phase 1
- Modality
- other
- Status
- active